Power and electronic dependency can become a limitation
Emergency, transport and degraded environments can impose charging constraints, limited infrastructure, cold exposure, vibration, logistics burden and reduced maintenance capacity.
Mechanical medical technology · Sophia Antipolis, France
Autonomous Mechanical Infusion Technology
PERFU+3 is a protected mechanical medical technology platform in pre-industrial maturation, designed for emergency, transport and constrained environments where reducing dependence on batteries, electronics or embedded software can be operationally valuable.
100% mechanical
No battery
No electronics
No embedded software
Mechanical by design
Pressure generation and essential operating functions without external electrical power.
100%mechanical operating principle
3French patent applications filed
Controlleddevelopment baseline under configuration management
Pre-industrialmaturation & transfer preparation
Why mechanical autonomy
Reducing technical dependency where conditions are demanding
PERFU+3 explores a deliberately simple approach to pressurised infusion: controlled mechanical compression of a flexible IV bag without a battery, electronic control unit or embedded software.
Keep the essential function mechanical
The platform is developed around passive mechanical functions for actuation, guidance, pressure application and limiting, with the objective of a robust and industrially transferable architecture.
PERFU+3 technology
A passive mechanical platform for controlled bag pressurisation
PERFU+3 is designed to apply controlled mechanical pressure to flexible infusion bags throughout use, without relying on electrical energy or software-driven control.
01
Mechanical pressure application
Stored mechanical energy and guided transmission are used to apply controlled compression to the infusion bag.
02
Passive limiting architecture
Pressure limiting is developed as an independent mechanical function without dependence on electronic sensing or software logic.
03
Human-factor oriented mechanics
Guiding, handling and anti-error features are integrated mechanically to support straightforward preparation and use.
04
Transfer-oriented engineering
The technology is supported by configuration-controlled engineering, risk work and verification planning for future industrial transfer.
Potential environments of use
Designed for demanding medical contexts
The technological relevance of PERFU+3 is strongest where autonomy, simplicity and reduced dependency on electrical infrastructure are desirable.
01
Emergency & pre-hospital
Rapid-deployment contexts where power infrastructure may not be immediately available.
02
Medical transport
Transport situations where compactness and reduced energy dependency can be valuable.
03
Operational health
Potential relevance for tactical and military medical environments requiring robust, battery-free equipment.
04
Disaster response
Degraded or mass-casualty environments in which normal electrical infrastructure cannot be assumed.
05
Remote & austere care
Remote, island, mountain or other constrained environments with demanding logistics.
06
Civil protection
Resilience and continuity-of-care scenarios where equipment independence can support operational readiness.
Defence positioning: military and tactical applications are potential use cases to be evaluated
with competent stakeholders. PERFU+3 is not presented as a military-qualified product.
Development status
A protected technology in pre-industrial maturation
PERFU+3 is not a commercial medical device. AXELYUM MEDTECH is continuing technical maturation, verification preparation and industrial-transfer structuring before partner-led industrialisation and regulatory execution.
Protected technology
The technology is supported by three French patent applications. Transfer and rights formalisation are managed separately from the public website.
Configuration management
A controlled development baseline is maintained under configuration management as the architecture matures.
Structured dossier
Design definition, requirements, risk work and verification documentation are progressively consolidated.
Preparation underway
Industrial-transfer documentation and partner-facing materials are being progressively prepared and maintained.
AXELYUM MEDTECH
Develop, protect, mature and transfer mechanical medical technologies
AXELYUM MEDTECH is a French MedTech technology company focused on intellectual property, mechanical medical-device engineering and preparation for industrial transfer.
The company does not position itself as the future series manufacturer. Its model is to create and mature protected technology assets, then engage qualified industrial partners for industrialisation, regulatory execution, manufacturing and market access.
- Legal name
- AXELYUM MEDTECH SASU
- SIREN / SIRET
- 105 779 011 · 105 779 011 00011
- Activity
- 72.19Z — R&D in physical and natural sciences
- Registered office
- Les Aqueducs – Bâtiment 3, 535 Route des Lucioles, 06560 Valbonne, France
- Founder
- Luc Pichotte — Président & Founder
- Business model
- Technology development · Licensing · Industrial transfer · Co-development
Industrial partnership
Built for qualified industrial dialogue
AXELYUM seeks partners able to assess the technology, contribute to its industrial maturation, execute the regulatory pathway and bring the resulting device to market.
AXELYUM MEDTECH contributes
- Protected technology and associated know-how
- Controlled engineering baseline and system architecture
- Structured engineering, risk and verification documentation
- Know-how transfer and technical support
- Flexible licensing or co-development framework
The industrial partner contributes
- Design-for-manufacture and industrialisation capability
- Series manufacturing and supplier qualification
- Regulatory strategy and conformity assessment
- Clinical / usability work where required
- Distribution, market access and post-market organisation
Non-confidential documents
Take PERFU+3 with you
Two-page non-confidential overview documents are available for professional and institutional circulation.
PERFU+3 Non-Confidential Overview
International overview of the technology, potential applications, maturation pathway and AXELYUM MEDTECH partnering model.
Download English PDFPERFU+3 — Présentation non confidentielle
Fiche française de présentation, destinée à la circulation institutionnelle et professionnelle.
Télécharger le PDF françaisQualified enquiries
Discuss PERFU+3 with AXELYUM MEDTECH
For industrial transfer, licensing, co-development, strategic partnership or institutional discussions. Detailed technical information is shared selectively and, where appropriate, under NDA.
Luc Pichotte · Président & Founder
AXELYUM MEDTECH SASU · Sophia Antipolis · France
luc.pichotte@axelyumhealth.com
+33 7 82 17 33 88 · no telephone support service
Use the secure contact form for professional enquiries. The direct email address remains available as a fallback. Please do not send confidential technical information before appropriate confidentiality arrangements are in place.
Open contact form